SUPRIYA LIFESCIENCE
Back to Income Statement
|
SUPRIYA LIFESCIENCE Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹828 Cr | ₹696 Cr | ₹570 Cr | ₹461 Cr | ₹530 Cr |
What is the latest Revenue of SUPRIYA LIFESCIENCE ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹828 Cr |
| Mar2025 | ₹696 Cr |
| Mar2024 | ₹570 Cr |
| Mar2023 | ₹461 Cr |
| Mar2022 | ₹530 Cr |
How is Revenue of SUPRIYA LIFESCIENCE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹828 Cr | 18.86 | |
| Mar2025 | ₹696 Cr | 22.12 | |
| Mar2024 | ₹570 Cr | 23.73 | |
| Mar2023 | ₹461 Cr | -13.04 | |
| Mar2022 | ₹530 Cr | - | |
Compare Revenue of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹6,811.9 Cr | 1.6% | -14% | 16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 1.6% |
-14% |
16.2% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses